Open Access

Open Access
This is a Gold Open Access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
License & Copyright
The Global Journal of Novel Pharma and Paramedical Research applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.
Article Processing Charge
All articles published in the Global Journal of Novel Pharma and Paramedical Research are published in Gold Open Access. In order to provide free access to readers, and to cover the costs of peer review, copyediting, typesetting, long-term archiving, and journal management, a one-time article processing charge (APC) of 20 USD (US Dollars) applies to papers accepted after peer review.
Global Journal of Novel Pharma and Paramedical Research does not charge a submission fee which means there are no charges for rejected articles. The length of an article and figures or supplementary data are not subject to additional fees by the journal. Some items (Editorials, Corrections, Addendums, Retractions, Comments, etc.) are published free of charge.
Local VAT or Sales Tax will be added if applicable.
The journal is currently free to the authors, all Article Processing Charges (APCs) are waived until the end of 2022.